Corbus Pharma Awards CMO 250k Shares and Options to Boost Pipeline Confidence
Corbus Pharma’s CMO receives a 58k‑share RSU and 192k‑share option grant—signaling executive confidence as lenabasum advances clinical milestones.
- CORBUS PHARMACEUTICALS HOLDI
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read